Ttt of Adenomyosis
ConditionAdenomyosis
Trial statusNot yet recruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexFemale
Age30-50
SponsorAl-Azhar University
About this trial
to evaluate use of Dienogest versus uterine arteries embolization in treatment of Adenomyosis-associated symptoms as dysmenorrhea, heavy menstrual bleeding and bulk-related symptoms
Eligibility criteria
Qualifiers
Age Group: 30-50 years
Women with adenomyosis
With or without small fibroids
Suffering from heavy menstrual bleeding, dysmenorrhea, and/or cycle- independent pain and bulk-related symptoms.
Disqualifiers
- Presence of a malignancy or pelvic infection.
An on-going pregnancy or a desire to conceive in the future.
Absolute contraindication for angiography (renal impairment).
Chronic debilitating diseases.
Trial design
Treatments tested in this trial
- Dienogest 2 mg orally
- UAE
Treatment groups
100 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov